Endpoints News· Nicole DeFeudis·· 3 天前AI 评分58
ESMO26：Merck 与 Moderna 个性化癌症疫苗数据获关注，后续工作才刚开始
#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
AI 导读
在西班牙马德里举行的欧洲肿瘤内科学会（ESMO）年会上，Merck 与 Moderna 的个性化癌症疫苗数据引发临床医生关注，被形容为“科学的胜利”。报道指出，数据公布之后，后续工作才刚刚开始。原文正文需免费注册后才能阅读，可见内容未披露具体疗效数据。
正文 · 原文
MADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news